The Journal of the Korea Contents Association (한국콘텐츠학회논문지)

The Korea Contents Association (한국콘텐츠학회)
권호 표지
DOI QR코드

DOI QR Code

The Relationship between R&D investment and Ownership Structure in KOSDAQ Pharmaceutical Firms

코스닥 제약기업의 연구개발투자와 소유구조 간의 관계

  • 이문재 (고려대학교 보건정책관리학부) ;
  • 최만규 (고려대학교 보건정책관리학부/고려대학교대학원 보건과학과/BK21PLUS 인간생명-상호작용 융합사업단)
  • Received : 2015.04.24
  • Accepted : 2015.05.12
  • Published : 2015.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study is to analyze the influence of the financial structure of pharmaceutical companies on R&D investment. 358 pharmaceutical firms listed in the KOSDAQ market from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price was extracted from KISVALUE-III of NICE Information Service Co., Ltd. STATA 12.0 was used as the statistical package for panel analysis. The summary of the findings and the interpretation of the significance of this are as follows: First, the shareholding ratio of major shareholders and foreigners had a positive influence on R&D investment. Second, the ratio of outside directors had a negative influence on R&D investment. Third, the shareholding ratio of institutional investors did not have a significant influence on R&D investment.

본 연구는 우리나라 코스닥 제약기업을 대상으로 소유구조가 제약기업의 연구개발투자(R&D)에 미치는 영향을 분석하였다. 실증분석을 위한 표본은 2000년부터 2012년까지 상장된 기업들 중 코스닥 제약기업을 대상으로 하였으며사용된 전체 표본은 13개년 자료로써 358개 관측치를 가진 불균형패널자료이다. 본 연구에 사용된 주요 변수들 중 개별기업 별 재무자료는 상장회사 협의회의 TS-2000을, 임원현황 및 주주분포 등은 금융감독원 전자공시 시스템의 각 기업 사업보고서 자료를 통해 자료를 직접 수집하였으며 기업나이, 기업크기 등은 NICE신용평가정보의 KISVALUE-III 등의 자료를 참고하였다. 연구결과, 첫째 주요주주율과 외국인투자율은 연구개발투자에 긍정적인 영향을 미쳤다. 둘째, 사외이사율은 연구개발투자에 부정적인 영향을 미쳤다. 셋째, 기관투자율은 통계적으로 유의한 결과를 미치지 못했다.

Keywords

References

  1. J. A. Dimasi, R. W. Hansen, and H. G. Grabowski, "The price of innovation: new estimates of drug development costs," Journal of health economics, Vol.22, No.2, pp.151-185, 2003. https://doi.org/10.1016/S0167-6296(02)00126-1
  2. H. G. Grabowski and J. Vernon, "The distribution of sales revenues from pharmaceutical innovation," Pharmacoeconomics, Vol.18, No.1, pp.21-32, 2000. https://doi.org/10.2165/00019053-200018001-00005
  3. C. I. Jo, "What Determines the Pharmaceutical R&D Investments?," Journal of Social Science, Vol.38, No.3, pp.273-290, 2012. https://doi.org/10.15820/khjss.2012.38.3.012
  4. M. C. Jensen and W. H. Meckling, "Theory of the firm: Managerial behavior, agency costs and ownership structure," Journal of financial economics, Vol.3, No.4, pp.305-360, 1976. https://doi.org/10.1016/0304-405X(76)90026-X
  5. A. D. Ghosh, D. Moon, and K. Tandon, "CEO ownership and discretionary investments," Journal of Business Finance & Accounting, Vol.34, No.5-6, pp.819-839, 2007. https://doi.org/10.1111/j.1468-5957.2007.02011.x
  6. C. S. Lee and W. H. Kim, "The Impacts of Ownership Structure on the Research and Development Investment," Korean Accounting Information Review, Vol.19, No.1, pp.67-81, 2003.
  7. Y. Kim and C. Cho, "Effects of Ownership Structure on Values of KOSDAQ Firms -In Times of R&D Investment Disclosure," Korean Corporation Management Review, Vol.14, No.2, pp.121-135, 2007.
  8. C. W. Hill and S. A. Snell, "External control, corporate strategy, and firm performance in research-intensive industries," Strategic Management Journal, Vol.9, No.6, pp.577-590, 1988. https://doi.org/10.1002/smj.4250090605
  9. R. E. Hoskisson et al., "Conflicting voices: The effects of institutional ownership heterogeneity and internal governance on corporate innovation strategies," Academy of Management Journal, Vol.45, No.4, pp.697-716, 2002. https://doi.org/10.2307/3069305
  10. J. H. Choi, "The Effect of Advertising and Research and Development Expenditures on the Firm Value: An Empitical Analysis by Tobin's Q," Korean Accounting Review, Vol.19, No.1, pp.103-124, 1994.
  11. R .Kochhar and P. David, "Institutional investors and firm innovation: A test of competing hypotheses," Strategic Management Journal, Vol.17, No.1, pp.73-84, 1996. https://doi.org/10.1002/(SICI)1097-0266(199601)17:1<73::AID-SMJ795>3.0.CO;2-N
  12. P. David, M. A. Hitt, and J. Gimeno, "The influence of activism by institutional investors on R&D," Academy of Management Journal, Vol.44, No.1, pp.144-157, 2001. https://doi.org/10.2307/3069342
  13. B. Baysinger and R. E. Hoskisson, "The composition of boards of directors and strategic control: Effects on corporate strategy," Academy of Management Review, Vol.15, No.1, pp.72-87, 1990. https://doi.org/10.5465/AMR.1990.4308231
  14. W. M. Cohen and D. A. Levinthal, "Absorptive capacity: a new perspective on learning and innovation," Administrative science quarterly, pp.128-152, 1990.
  15. J. H. Park and Y. Kim, "A split decision: Institutional investor types and research and development investment," Journal of Strategic Management, Vol.15, No.3, pp.19-42, 2012. https://doi.org/10.17786/jsm.2012.15.3.002
  16. B. R. Golden and E. J. Zajac, "When will boards influence strategy? Inclination$\times$ power= strategic change," Strategic Management Journal, Vol.22, No.12, pp.1087-1111, 2001. https://doi.org/10.1002/smj.202
  17. P. Wright et al., "The structure of ownership and corporate acquisition strategies," Strategic Management Journal, Vol.23, No.1, pp.41-53, 2002. https://doi.org/10.1002/smj.208
  18. J. E. Bethel and J. Liebeskind, "The effects of ownership structure on corporate restructuring," Strategic Management Journal, Vol.14, No.S1, pp.15-31, 1993. https://doi.org/10.1002/smj.4250140904
  19. T. R. Eisenmann, "The effects of CEO equity ownership and firm diversification on risk taking," Strategic Management Journal, Vol.23, No.6, pp.513-534, 2002. https://doi.org/10.1002/smj.236
  20. M. C. Jensen, "Agency costs of free cash flow, corporate finance, and takeovers," The American Economic Review, Vol.76, No.2, pp.323-329, 1986.
  21. H. K. Steensma and K. G. Corley, "Organizational context as a moderator of theories on firm boundaries for technology sourcing," Academy of Management Journal, Vol.44, No.2, pp.271-291, 2001. https://doi.org/10.2307/3069455
  22. R. V. Aguilera and G. Jackson, "The cross-national diversity of corporate governance: Dimensions and determinants," Academy of Management Review, Vol.28, No.3, pp.447-465, 2003. https://doi.org/10.5465/AMR.2003.10196772
  23. T. Mitton, "A cross-firm analysis of the impact of corporate governance on the East Asian financial crisis," Journal of financial economics, Vol.64, No.2, pp.215-241, 2002. https://doi.org/10.1016/S0304-405X(02)00076-4
  24. R. Porta, F. Lopez-De-Silanes, and A. Shleifer, "Corporate ownership around the world," The journal of finance, Vol.54, No.2, pp.471-517, 1999. https://doi.org/10.1111/0022-1082.00115
  25. K. Ramaswamy, M. Li, and R. Veliyath, "Variations in ownership behavior and propensity to diversify: A study of the Indian corporate context," Strategic Management Journal, Vol.23, No.4, pp.345-358. https://doi.org/10.1002/smj.227
  26. S. Douma, R. George, and R. Kabir, "Foreign and domestic ownership, business groups, and firm performance: Evidence from a large emerging market," Strategic Management Journal, Vol.27, No.7, pp.637-657, 2006. https://doi.org/10.1002/smj.535
  27. J. A. Pearce and S. A. Zahra, "The relative power of CEOs and boards of directors: Associations with corporate performance," Strategic Management Journal, Vol.12, No.2, pp.135-153, 1991. https://doi.org/10.1002/smj.4250120205
  28. E. F. Fama and M. C. Jensen, "Separation of ownership and control. Journal of law and economics," Vol.26, No.2, pp.301-325, 1983. https://doi.org/10.1086/467037
  29. J. D. Westphal, "Board games: How CEOs adapt to increases in structural board independence from management," Administrative Science Quarterly, pp.511-537, 1998.